The effectiveness of interventions to improve the seasonal influenza vaccination uptake among nurses: A systematic review.
Autorzy:
Flanagan P; School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland. Dowling M; School of Nursing and Midwifery, University of Galway, Galway, Ireland. Sezgin D; School of Nursing and Midwifery, University of Galway, Galway, Ireland. MereckieneJ; Health Protection Surveillance Centre, Dublin, Ireland. Murphy L; School of Nursing and Midwifery, University of Limerick, Galway, Ireland. Giltenane M; School of Nursing and Midwifery, University of Limerick, Galway, Ireland. Carr P; School of Nursing and Midwifery, University of Galway, Galway, Ireland. Gethin G; School of Nursing and Midwifery, University of Galway, Galway, Ireland.
Pokaż więcej
Źródło:
Journal of infection prevention [J Infect Prev] 2023 Nov; Vol. 24 (6), pp. 268-277. Date of Electronic Publication: 2023 Oct 20.
Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults.
Autorzy:
Humphreys H; Department of Clinical Microbiology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland. Corcoran M; Department of Clinical Microbiology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland. MereckieneJ; Health Services Executive - Health Protection Surveillance Centre, Dublin, Ireland. Cunney R; Department of Clinical Microbiology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.; Department of Microbiology, Children's Health Ireland at Temple Street, Dublin, Ireland. Cotter S; Health Services Executive - Health Protection Surveillance Centre, Dublin, Ireland.
Pokaż więcej
Źródło:
Epidemiology and infection [Epidemiol Infect] 2023 Jan 26; Vol. 151, pp. e27. Date of Electronic Publication: 2023 Jan 26.
Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018.
Autorzy:
Corcoran M; From the Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland. MereckieneJ; Health Protection Surveillance Centre, Dublin, Ireland. Cotter S; Health Protection Surveillance Centre, Dublin, Ireland. Murchan S; Health Protection Surveillance Centre, Dublin, Ireland. Cunney R; From the Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.; Department of Microbiology, Children's Health Ireland at Temple Street, Dublin, Ireland. Humphreys H; Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, Dublin, Ireland.; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Autorzy:
Savulescu C; Epiconcept, Paris, France. Krizova P; National Institute of Public Health, Prague, Czech Republic. Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark. Ladhani S; Public Health England, London, United Kingdom. Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland. Levy C; ACTIV, Créteil, France. MereckieneJ; Health Protection Surveillance Centre Dublin, Ireland. Knol M; National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Winje BA; Norwegian Institute of Public Health, Oslo, Norway. Ciruela P; Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain. de Miguel S; General Directorate of Public Health Madrid, Spain. Guevara M; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain. MacDonald L; Public Health Scotland, Glasgow, Scotland, UK. Kozakova J; National Institute of Public Health, Prague, Czech Republic. Slotved HC; Statens Serum Institut, Copenhagen, Denmark. Fry NK; Public Health England, London, United Kingdom. Pekka Nuorti J; National Institute for Health and Welfare, Helsinki, Finland; Tampere University, Tampere, Finland. Danis K; Santé publique France, the National Public Health Institute, Saint-Maurice, France. Corcoran M; Temple Street Children's University Hospital, Irish Pneumococcal Reference Laboratory, Dublin, Ireland. van der Ende A; Academic Medical Centre, National Reference Laboratory for Bacterial Meningitis, Amsterdam, the Netherlands. Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway. Munoz-Almagro C; Hospital Sant Joan de Déu, and International University of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain. Sanz JC; General Directorate of Public Health Madrid, Spain. Castilla J; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain. Smith A; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary & MVLS, University of Glasgow, Glasgow, Scotland, UK. Colzani E; European Centre for Disease Prevention and Control, Stockholm, Sweden. Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden. Hanquet G; Epiconcept, Paris, France; Antwerp university, Antwerp, Belgium. Electronic address: .
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project.
Autorzy:
Bennett JC; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Hetrich MK; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Garcia Quesada M; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Sinkevitch JN; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Deloria Knoll M; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Feikin DR; Independent Consultant, 1296 Coppet, Switzerland. Zeger SL; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Kagucia EW; KEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya. Cohen AL; World Health Organization, 1202 Geneva, Switzerland. Ampofo K; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA. Brandileone MC; National Laboratory for Meningitis and Pneumococcal Infections, Center of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo 01246-902, Brazil. Bruden D; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA. Camilli R; Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), 00161 Rome, Italy. Castilla J; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, 31003 Pamplona, Navarra, Spain. Chan G; Singapore Ministry of Health, Communicable Diseases Division, Singapore 308442, Singapore. Cook H; Centre for Disease Control, Department of Health and Community Services, Darwin, NT 8000, Australia. Cornick JE; Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool CH64 7TE, UK.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, P.O. Box 30096, Chichiri, Blantyre 3, Malawi. Dagan R; Faculty of Health Sciences, Ben-Gurion University of the Negev, 8410501 Beer-Sheva, Israel. Dalby T; Bacteria, Parasites and Fungi, Statens Serum Institut, DK-2300 Copenhagen, Denmark. Danis K; Santé Publique France, the French National Public Health Agency, Saint Maurice CEDEX, 94415 Paris, France. de Miguel S; Epidemiology Department, Dirección General de Salud Pública, 28009 Madrid, Spain. De Wals P; Department of Social and Preventive Medicine, Laval University, Québec, QC G1V 0A6, Canada. Desmet S; Department of Microbiology, Immunology and Transplantation, KU Leuven, BE-3000 Leuven, Belgium.; National Reference Centre for Streptococcus Pneumoniae, University Hospitals Leuven, 3000 Leuven, Belgium. Georgakopoulou T; National Public Health Organisation, 15123 Athens, Greece. Gilkison C; Epidemiology Team, Institute of Environmental Science and Research, Porirua, 5240 Wellington, New Zealand. Grgic-Vitek M; Communicable Diseases Centre, National Institute of Public Health, 1000 Ljubljana, Slovenia. Hammitt LL; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.; KEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya. Hilty M; Swiss National Reference Centre for Invasive Pneumococci, Institute for Infectious Diseases, University of Bern, 3012 Bern, Switzerland. Ho PL; Department of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong, China. Jayasinghe S; National Centre for Immunisation Research and Surveillance and Discipline of Child and Adolescent Health, Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia. Kellner JD; Department of Pediatrics, University of Calgary, and Alberta Health Services, Calgary, AB T3B 6A8, Canada. Kleynhans J; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, 2000 Johannesburg, South Africa. Knol MJ; National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands. Kozakova J; National Institute of Public Health (NIPH), 100 42, Praha Czech Republic. Kristinsson KG; Department of Clinical Microbiology, Landspitali-The National University Hospital, Hringbraut, 101 Reykjavik, Iceland. Ladhani SN; Immunisation and Countermeasures Division, Public Health England, London NW9 5EQ, UK. MacDonald L; Public Health Scotland, Glasgow G2 6QE, UK. Mackenzie GA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel St, London, WC1E 7HT, UK.; Medical Research Council Unit the Gambia atLondon School of Hygiene & Tropical Medicine, P.O. Box 273, Banjul, The Gambia.; New Vaccines Group, Murdoch Children's Research Institute, Parkville, Melbourne, 3052, Victoria, Australia. Mad'arová L; National Reference Centre for Pneumococcal and Haemophilus Diseases, Regional Authority of Public Health, 975 56 Banská Bystrica, Slovakia. McGeer A; Toronto Invasive Bacterial Diseases Network, Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada. MereckieneJ; HSE Health Protection Surveillance Centre, Mountjoy, Dublin D01 A4A3, Ireland. Morfeldt E; Department of Microbiology, Public Health Agency of Sweden, 171 82 Solna, Sweden. Mungun T; National Center of Communicable Diseases (NCCD), Ministry of Health, Bayanzurkh District, Ulaanbaatar 13336, Mongolia. Muñoz-Almagro C; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.; Medicine Department, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.; Molecular Microbiology Department, Hospital Sant Joan de Déu Research Institute, 08950 Esplugues de Llobregat, Barcelona, Spain. Nuorti JP; Department of Health Security, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.; Health Sciences Unit, Faculty of Social Sciences, University of Tampere, 33100 Tampere, Finland. Paragi M; Centre for Medical Microbiology, National Laboratory of Health, Environment and Food, 2000 Maribor, Slovenia. Pilishvili T; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. Puentes R; Instituto de Salud Pública de Chile, 7780050 Santiago, Santiago Metropolitan, Chile. Saha SK; Child Health Research Foundation, Dhaka 1207, Bangladesh. Sahu Khan A; Ministry of Health and Medical Services, Suva, Fiji. Savrasova L; Centre for Disease Prevention and Control of Latvia, 1005 Riga, Latvia.; Doctoral Studies Department, Riga Stradinš University, 1007 Riga, Latvia. Scott JA; KEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya. Skoczyńska A; National Reference Centre for Bacterial Meningitis, National Medicines Institute, 00-725 Warsaw, Poland. Suga S; Infectious Disease Center and Department of Clinical Research, National Hospital Organization Mie Hospital, Tsu, Mie 514-0125, Japan. van der Linden M; National Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany. Verani JR; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.; Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global Health Protection (DGHP), Nairobi, Kenya. von Gottberg A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa.; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein, Johannesburg 2000, South Africa. Winje BA; Department of Infection Control and Vaccine, Norwegian Institute of Public Health, 0456 Oslo, Norway. Yildirim I; Department of Pediatrics, Yale New Haven Children's Hospital, New Haven, CT 06504, USA. Zerouali K; Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca 20250, Morocco.; Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca 20000, Morocco. Hayford K; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy.
Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands.
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.
Autorzy:
Hanquet G; EpiConcept, Paris, France.; Antwerp University, Antwerp, Belgium. Krizova P; National Institute of Public Health, Prague, Czech Republic. Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark. Ladhani SN; Public Health England, London, UK. Nuorti JP; National Institute for Health and Welfare, Helsinki, Finland.; University of Tampere, Tampere, Finland. Lepoutre A; Santé publique France, Saint-Maurice, France. MereckieneJ; Health Protection Surveillance Centre, Dublin, Ireland. Knol M; National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Winje BA; Norwegian Institute of Public Health, Oslo, Norway. Ciruela P; Public Health Agency of Catalunya, Barcelona, Spain.; CIBER Epidemiología y Salud Pública, Madrid, Spain. Ordobas M; General Directorate of Public Health, Madrid, Spain. Guevara M; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain. McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK. Morfeldt E; Public Health Agency of Sweden, Solna, Sweden. Kozakova J; National Institute of Public Health, Prague, Czech Republic. Slotved HC; Statens Serum Institut, Copenhagen, Denmark. Fry NK; Public Health England, London, UK. Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland. Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France. Corcoran M; Irish Pneumococcal Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland. van der Ende A; Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Centre, Amsterdam, The Netherlands. Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway. Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Recerca Pediátrica, Hospital Sant Joan de Deu, Universitat Internacional de Catalunya, Barcelona, Spain. Latasa P; General Directorate of Public Health, Madrid, Spain. Castilla J; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain. Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK. Henriques-Normark B; Public Health Agency of Sweden, Solna, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. Whittaker R; European Centre for Disease Prevention and Control, Stockholm, Sweden. Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden. Savulescu C; EpiConcept, Paris, France.
Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).
A scoping review of the reasons for and approaches to non-uptake of pertussis and influenza vaccinations in pregnant women in the United Kingdom and Ireland.
A Cross-Sectional Survey of Knowledge, Attitude, and Practices Regarding Influenza Vaccination Among Jordanians Aged 18-64 Years with Chronic Diseases.
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
Autorzy:
Jorgensen P; WHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark. Electronic address: . MereckieneJ; Health Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland. Cotter S; Health Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland. Johansen K; European Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden. Tsolova S; European Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden. Brown C; WHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2018 Jan 25; Vol. 36 (4), pp. 442-452. Date of Electronic Publication: 2017 Dec 26.
Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
Autorzy:
Savulescu C; Epidemiology Department, EpiConcept, Paris, France. Electronic address: . Krizova P; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic. Lepoutre A; Infectious Disease Department, French National Agency for Public Health, Saint-Maurice, France. MereckieneJ; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland. Vestrheim DF; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway. Ciruela P; General Sub-Directorate for Surveillance and Public Health Emergency Response, Public Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain. Ordobas M; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain. Guevara M; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain. McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK. Morfeldt E; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden. Kozakova J; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic. Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France. Cotter S; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland. Winje BA; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway. Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain; Molecular Microbiology Department, Hospital Sant Joan de Déu, Barcelona, Spain; International University of Catalunya, Barcelona, Spain. Garcia L; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain. Castilla J; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain. Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK. Henriques-Normark B; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden; Department of Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. Celentano LP; Office of Chief Scientist Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden. Hanquet G; Epidemiology Department, EpiConcept, Paris, France.
Impact of national recommendations for routine pertussis vaccination during pregnancy on infant pertussis in Ontario, Canada: a population-based time-series study.
Highly Resistant Serotype 19A Streptococcus pneumoniae of the GPSC1/CC320 Clone from Invasive Infections in Poland Prior to Antipneumococcal Vaccination of Children.
Comprehensive assessment of the implementation of maternal immunization programs in Italy: A national survey across maternity care units.
Autorzy:
Vilca LM; Unit of Obstetrics and Gynecology, Buzzi Hospital-ASST Fatebenefratelli Sacco, University of Milan, Milan, Italy. Sala V; Unit of Obstetrics and Gynecology, Buzzi Hospital-ASST Fatebenefratelli Sacco, University of Milan, Milan, Italy. Chiantera A; Italian Society of Gynecology and Obstetrics, Rome, Italy. Colacurci N; Italian Society of Gynecology and Obstetrics, Rome, Italy. Cetin I; Unit of Obstetrics and Gynecology, Buzzi Hospital-ASST Fatebenefratelli Sacco, University of Milan, Milan, Italy.
Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
Autorzy:
Giese C; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; HSE Health Protection Surveillance Centre, Dublin, Ireland. MereckieneJ; HSE Health Protection Surveillance Centre, Dublin, Ireland. Danis K; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. O'Donnell J; HSE Health Protection Surveillance Centre, Dublin, Ireland. O'Flanagan D; HSE Health Protection Surveillance Centre, Dublin, Ireland. Cotter S; HSE Health Protection Surveillance Centre, Dublin, Ireland. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2016 Jul 12; Vol. 34 (32), pp. 3657-62. Date of Electronic Publication: 2016 Jun 07.
Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).
Understanding the barriers and facilitators of COVID-19 vaccine hesitancy amongst healthcare workers and healthcare students worldwide: An umbrella review protocol.
Barriers and enablers to influenza vaccination uptake in adults with chronic respiratory conditions: applying the behaviour change wheel to specify multi-levelled tailored intervention content.
Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco.
Exploring Perceptions and Practices Regarding Adult Vaccination against Seasonal Influenza, Tetanus, Pneumococcal Disease, Herpes Zoster and COVID-19: A Mixed-Methods Study in Greece.
Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort study.
Vaccination against Streptococcus pneumoniae in Children Born between 2015 and 2018 in Poland—How Has the Introduction of Free Compulsory Pneumococcal Vaccination Affected Its Uptake?
Knowledge, attitudes and adherence towards influenza and other vaccinations among healthcare workers at the University Hospital of Palermo, Italy, during the first COVID-19 pandemic season (2020/2021).
Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants.
Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine.
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age.
Acceptance of seasonal influenza vaccination and associated factors among pregnant women in the context of COVID-19 pandemic in China: a multi-center cross-sectional study based on health belief model.
Parents' intention to get vaccinated and to have their child vaccinated against COVID-19: cross-sectional analyses using data from the KUNO-Kids health study.
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States.
Effect of Primary Care Center Characteristics, Healthcare Worker Vaccination Status and Patient Economic Setting on Patient Influenza Vaccination Coverage Rates.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies